Acquisition in the luxury goods industry
Rino Mastrotto Group S.p.A., a portfolio company of NB Renaissance Partners Holdings Sarl, has acquired a majority stake in Mapel Group S.r.l.
Rino Mastrotto Group operates in the tanning and leather processing sector for the automotive, furniture and footwear industries. The group is specialized in the production and sale of premium bovine and calf leather for fashion and luxury items, high-quality leather for automotive steering wheels, with a growing presence in seats and dashboard, and for the upholstery industry.
Mapel Group is a company specialized in the manufacturing and sale of ribbons, inserts and accessories for luxury goods. Mapel Group, with over 30 years of experience in the market for leather tapes and components, is one of the leading Italian companies in this field and operates through two subsidiaries: Mapel Textile and Mapel Components.
The Leni and Ugolini families, the company’s founders, will retain a minority stake and continue to lead the company with key management roles.
Oaklins’ team in Italy acted as buy-side advisor to Rino Mastrotto Group (NB Renaissance) in the acquisition of a majority stake in Mapel Group.
Talk to the deal team
Related deals
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more